Semaglutide

Product Name： Semaglutide Cas No. 910463-68-2 Sequence His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(PEG2-PEG2-γ-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly Molecular Formula C187H291N45O59 Molar Mass 4,113.58 Da The Maximum...

Product Name： Semaglutide
Cas No. 910463-68-2
Sequence His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(PEG2-PEG2-γ-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly
Molecular Formula C187H291N45O59
Molar Mass 4,113.58 Da
The Maximum Unspecified Impurity ≤0.1%
Storage Temperature 2-8℃
Packing Size 50G/Bottle or at customers reqirement.

About

Semaglutide is a peptide-based therapeutic that belongs to the glucagon-like peptide-1 receptor agonist (GLP-1 RA) class of drugs. Semaglutide is a synthetic version of a naturally occurring peptide called glucagon-like peptide-1 (GLP-1), which is produced in the intestines. GLP-1 is a hormone that plays a key role in regulating blood sugar levels. It stimulates insulin secretion from the pancreas, reduces glucagon production (which normally raises blood sugar levels), slows down the emptying of the stomach, and promotes a feeling of fullness after meals. These effects collectively contribute to improved glycemic control and can be particularly beneficial for individuals with type 2 diabetes. Semaglutide is designed to mimic the effects of GLP-1. It has been modified to have a longer duration of action in the body, allowing it to be administered less frequently than the natural GLP-1 hormone. This makes it suitable for once-weekly dosing, which can improve patient adherence to treatment regimens.